.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Primary Biliary Cholangitis (PBC) is a chronic autoimmune condition that significantly impacts the liver over time. Although many patients remain stable with early treatment, others progress toward liver failure. Consequently, clinicians must understand the substantial economic burden associated with advanced disease. A recent retrospective study has quantified Primary Biliary Cholangitis costs, focusing specifically on hepatic decompensation and liver transplantation events.
Researchers analyzed data from a large administrative database to evaluate these medical expenses. Specifically, they looked at two cohorts: patients with hepatic decompensation and those undergoing liver transplantation. The results were striking. For hepatic decompensation events, the mean cost per event reached $63,612.09. However, this figure rose significantly to $116,424.25 when a readmission occurred within 30 days. In contrast, events without readmission averaged roughly $43,405.
Furthermore, the liver transplantation cohort faced even higher financial demands. The total mean cost per patient for a transplant was approximately $328,336.60. Notably, the hospitalization for the transplant itself accounted for the largest share of the expense, averaging $226,908.70 per patient. These findings highlight that proactive patient management is vital. By slowing disease progression, healthcare providers may help to mitigate the heavy economic burden of PBC-related complications.
Readmissions significantly inflate the cost of care for hepatic decompensation. In this study, events requiring readmission within 30 days were nearly three times more expensive than those that did not require a return to the hospital.
The actual hospitalization for the transplant procedure is the most expensive component. It averages over $226,000, which covers the surgery and immediate post-operative care.
Yes, appropriate management to prevent disease progression can help avoid high-cost events like decompensation and the need for liver transplantation.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Gish RG et al. Cost of hepatic decompensation and liver transplantation events in primary biliary cholangitis: a retrospective observational study. J Comp Eff Res. 2026 Feb 16. doi: 10.57264/cer-2025-0110. PMID: 41693640.
Lammers EN et al. Healthcare resource utilization and cost burden in patients with primary biliary cholangitis. Value Health. 2024;27(6):S1.
Harms MH et al. Economic burden of primary biliary cholangitis by line of therapy. J Comp Eff Res. 2025 Dec 4. doi: 10.57264/cer-2025-0012.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A retrospective study quantifies the high costs of PBC complications, showing mean liver transplant costs of $328,336 and decompensation at $63,612 per even...
5 months ago
A Bayesian network meta-analysis evaluated non-surgical treatments for benign thyroid nodules, finding thermal ablation techniques like laser and radiofrequency ablation superior in nodule volume reduction, whereas levothyroxine showed the strongest TSH suppression without significant changes in FT3 or FT4.
Today
A retrospective study demonstrates that deep learning models using longitudinal digital breast tomosynthesis significantly enhance 5-year breast cancer risk prediction compared to single-timepoint imaging and clinical models.
Today
Researchers developed poly(trimethylene carbonate)-based polymersomes loaded with L-arginine for ROS-triggered nitric oxide release. This mild, stable nano-delivery system produces gas in response to hydrogen peroxide, offering a promising, targeted platform for cardiovascular, surgical, and oncological therapy.
Today
Researchers developed a Haversian-inspired composite scaffold that addresses delayed vascularization and wet-state mechanical deterioration in critical bone defect repair. By integrating spatially programmed calcium phosphate minerals and selective silica reinforcement, the design promotes vascularized bone repair.
Yesterday
A landmark study analyzing over 56,000 adult health records in Delhi-NCR reveals that hypertension and diabetes coexistence affects nearly 5% of adults. The prevalence doubles expected rates and rises sharply after age 40. Early integrated screening is essential to prevent microvascular and macrovascular complications.
Today
